Dr Jennifer Dwyer discusses the results from her randomized, double-blind, placebo-controlled crossover trial study that found a reduction in depression scores at 24 hours post treatments with ketamine...
Jennifer Dwyer, MD, PhD, discusses her study's findings that intravenous ketamine appears safe and effective for adolescent depression and the balance between caution with novel treatments and losing...
Consultant360 spoke with Leslie Heinberg, PhD, from Cleveland Clinic, about the importance of cognitive behavioral therapy and a multidisciplinary approach to treating obesity, especially among those with...
Consultant360 spoke with Adam Chekroud, PhD, of Spring Health and Yale School of Medicine, who recently led a study investigating the frequency, duration, and types of exercise that confer the most mental...
Daniel Blumberger, MD, MSc, from the Centre for Addiction and Mental Health in Canada shares the ins and outs of intermittent theta burst stimulation—the shortened brain stimulation protocol newly approved...
